Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

CEO

Country

ISIN

JP3266500002

Listings

TSE

4596.TSE

0 Comments

Share your thoughts

FAQ

What is Kubota Pharmaceutical stock price today?▼

The current price of KBBTF is $0.96 USD — it has increased by +0% in the past 24 hours. Watch Kubota Pharmaceutical stock price performance more closely on the chart.

What is Kubota Pharmaceutical stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Kubota Pharmaceutical stocks are traded under the ticker KBBTF.

What is Kubota Pharmaceutical market cap?▼

Today Kubota Pharmaceutical has the market capitalization of 52.14M

What were Kubota Pharmaceutical earnings last quarter?▼

KBBTF earnings for the last quarter are -9.44 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.

In which sector is Kubota Pharmaceutical located?▼

Kubota Pharmaceutical operates in the Manufacturing sector.

When did Kubota Pharmaceutical complete a stock split?▼

Kubota Pharmaceutical has not had any recent stock splits.